Alexander T. Sandhu (
Jay Bhattacharya is a professor of medicine in the Center for Health Policy and the Center for Primary Care and Outcomes Research, Department of Medicine, Stanford University. He is also a senior research fellow at Acumen, LLC.
Health Aff (Millwood). 2020 Sep;39(9):1495-1503. doi: 10.1377/hlthaff.2020.00440.
Medicare's Merit-based Incentive Payment System (MIPS) includes episode-based cost measures that evaluate Medicare expenditures for specific conditions and procedures. These measures compare clinicians' cost performance and, along with other MIPS category scores, determine Medicare Part B clinician payment adjustments. The measures do not include risk adjustment for social risk factors. We found that adjusting for individual and community social risk did not have a meaningful impact on clinicians' cost measure performance. Across eight cost measures, 1.4 percent of clinician groups, on average, had an absolute change in their cost measure performance percentile of 10 percent or more (range, 0.4-3.4 percent). Prior analyses have generally found higher health care costs for patients with increased social risk. MIPS episode-based cost measures are distinct from previous cost measures because they only include costs related to the specific condition being evaluated. This unique approach may explain why costs were similar for patients with high and low social risk before any risk adjustment. MIPS episode-based cost measures do not appear to penalize clinicians who primarily care for patients with increased social risk.
医疗保险的基于绩效的激励支付系统 (MIPS) 包括基于疾病的成本措施,这些措施评估特定疾病和程序的医疗保险支出。这些措施比较了临床医生的成本表现,以及其他 MIPS 类别分数,从而确定了医疗保险 B 部分临床医生的支付调整。这些措施不包括社会风险因素的风险调整。我们发现,对个人和社区社会风险进行调整对临床医生的成本衡量表现没有显著影响。在八项成本衡量标准中,平均有 1.4%的临床医生群体的成本衡量表现百分位变化绝对值达到 10%或更高(范围为 0.4-3.4%)。先前的分析通常发现,社会风险增加的患者的医疗保健费用更高。MIPS 基于疾病的成本衡量标准与以前的成本衡量标准不同,因为它们只包括与正在评估的特定疾病相关的成本。这种独特的方法可能解释了为什么在进行任何风险调整之前,高社会风险和低社会风险的患者的成本相似。MIPS 基于疾病的成本衡量标准似乎不会惩罚主要照顾社会风险增加的患者的临床医生。